Symposier - NEJM: FLAIR Superior to Angioplasty
Links shared publicly online about this topic.
- 1,379total visits
Symposier - NEJM: FLAIR Superior to Angioplasty
Uploaded and Shared in Youtube by: MultiVuVideos C. R. Bard, Inc. (NYSE: BCR) today announced the publication of trial results by The New England Journal of Medicine (NEJM) showing the Bard FLAIR® Endovascular Stent Graft maintains the patency of dialysis access grafts more effectively than balloon angioplasty alone. It is the first prospective study to demonstrate the superiority of a new therapy over balloon angioplasty for hemodialysis patients who experience stenoses, or narrowing, where th
View full resource at symposier.com
Tags: Dialysis
Most Recently Shared on March 31, 2012 at 8:37 pm By:
EndovascularStent Graft maintains the patency of dialysis access grafts more effectively than balloon angioplasty alone http://t.co/ksOe6gpW
Advertisement
